perfluoropentane has been researched along with Cardiac Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shaw, LJ | 1 |
Abrahamson, D; Aurigemma, GP; Byrd, BF; Chrysant, SG; Cohen, JL; DeMaria, AN; Foster, E; Grayburn, PA; Hack, TC; Jacobson, SA; Kitzman, DW; Klein, AL; Klodas, E; Panza, JA; Perez, JE; Picard, MH; Raichlen, JS; Sahn, DJ; Segar, DS; Vannan, MA; Weiss, JL | 1 |
1 trial(s) available for perfluoropentane and Cardiac Diseases
Article | Year |
---|---|
Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
Topics: Adult; Aged; Contrast Media; Echocardiography; Emulsions; Endocardium; Female; Fluorocarbons; Heart Diseases; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged; Sensitivity and Specificity; Single-Blind Method | 1998 |
1 other study(ies) available for perfluoropentane and Cardiac Diseases
Article | Year |
---|---|
Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications.
Topics: Albumins; Contrast Media; Coronary Disease; Cost-Benefit Analysis; Echocardiography; Female; Fluorocarbons; Heart Diseases; Humans; Male; Myocardial Ischemia | 1997 |